NAMSW

Conviction 43HealthcareScan · Thu, Jun 25, 2026

NAMSW$21.40+0.00%

ResistanceSupportVol 14

Vol MA14 1.15K

Mar 25Apr 13Apr 30May 18Jun 5Jun 24

NewAmsterdam Pharma Co N.V.PHARMACEUTICAL PREPARATIONSwww.newamsterdampharma.com ↗

Price21.40

Change+0.00%

Gap—

Rel volume0.35×

Avg volume922

Avg $ vol17.66K

SMA 2011.24

SMA 5010.40

SMA 20011.66

Price vs 50+105.73%

Price vs 200+83.50%

MA stackmixed

50/200 cross—

Supertrendup · -1.25

RSI (14)56

MACD hist-0.34

MACD crossbear · 4d

Stoch %K / %D100 / 33

ADX (14)9

+DI / −DI56 / 43

RSI divergence—

MACD divergence—

ATR %+36.73%

ADR %2.45%

52w high29.99

52w low0.0000

From 52w high-28.64%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width367.15%

%B0.75

Donchian pos77.97%

Donchian high27.45

Donchian low0.0000

AVWAP (52w high)20.84

vs AVWAP high+2.68%

AVWAP (52w low)16.97

vs AVWAP low+26.09%

OBV trendFlat

Chaikin MF (20)-0.83

Today vs 20d0.35×

Avg vol (14d)1.15K

Avg vol (20d)922

Avg $ vol (20d)17.66K

Market cap2.5B

RS 3m (vs SPY)+5.32%

RS 6m (vs SPY)-12.79%

RS line new highNo

Trend template3/8

Technical rank68.5

1 week+14.47%

1 month-11.79%

3 months+17.58%

6 months-5.06%

1 year—

YTD-7.36%

P/E-12.27

P/B3.76

P/S111.17

P/FCF-16.90

EPS-1.72

Div yield—

ROE-30.64%

ROA-27.82%

Debt/Eq—

Current9.76

EV/EBITDA-9.07

Gross margin—

Net margin-905.74%

Rev growth-50.61%

EPS growth15.64%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.04B

Revenue3.04M

Net income-48.44M

Gross profit—

Free cash flow-148.03M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out4.6M

Employees100

ListedWed, Nov 23, 2022

Free float62.89M

Float %53.8%

Short interest71

Days to cover0.3d

Short volume—

Squeeze score2 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction43 / 100

Pattern quality—

Tech rank68.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance28.95

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NAMSW

All disclosures →

No recent disclosed trades by Congress in NAMSW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NAMSW

No recent insider (Form 4) filings in NAMSW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in NAMSW

EDGAR →

No recent SEC filings on file for NAMSW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.